The author reflects on how his relationship with Jeremy Safran during graduate school continues to inform his thinking around pedagogy and clinical training. Safran's emphasis on independent inquiry is highlighted, especially regarding the importance of seeking out perspectives and evidence that come into conflict with one's primary orientation. The author argues that Safran's pedagogical stance could be described as inhabiting a state of "pre-judgment," which is essential in both clinical and pedagogical contexts in the psychoanalytic field.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1057/s11231-024-09471-9 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
How Quickly Multiple Medication Use Can Start: A Medication for Every Complaint on the First Visit Compromising the Ability to Determine Cause and Effect.
J Psychiatr Pract
January 2025
Department of Psychiatry and Behavioral Sciences, School of Medicine, University of Kansas, Wichita, KS.
This article presents a case demonstrating that multiple medication use can begin on the first outpatient visit if the prescriber makes multiple psychiatric diagnoses and then feels the need to treat each diagnosis with a different central nervous system active medication labeled for each indication. This approach poses potential problems. First, a single drug or perhaps 2 drugs, in this case, may have been sufficient as initial and perhaps final treatment.
View Article and Find Full Text PDFThe social life of creative methods: Filmmaking, fabulation and recovery.
Br J Sociol
December 2024
Artist in Residence, Centre for Health, Arts, Society and the Environment (CHASE), University of Liverpool, Liverpool, UK.
In this article we consider the theoretical and methodological implications of Deleuzian fabulation for research on recovery from drugs and alcohol as an alternative way of making and doing methods in sociology. The article draws on data produced as part of an ongoing interdisciplinary research collaboration, begun in 2019, with the visual artist and filmmaker Melanie Manchot, social scientists Nicole Vitellone and Lena Theodoropoulou, and people in recovery from drugs and alcohol engaged in the production of Manchot's first feature film STEPHEN. This project attends to the methodological practice of filmmaking as a way of thinking with and alongside colleagues from divergent disciplines about the role of methods, concepts and practices for confronting and resisting processes of stigmatisation.
View Article and Find Full Text PDFLong-Term Potentiation: The Accidental Discovery.
Hippocampus
January 2025
Institute of Basic Medical Sciences, University of Oslo, Oslo, Norway.
Long-term potentiation (LTP), is a type of synaptic plasticity now considered essential for learning and memory. Here I tell the story of how I accidentally discovered in 1966 in the laboratory of Per Andersen in Oslo, Norway, because I was not looking for it. It just emerged.
View Article and Find Full Text PDFYour lies don't leave me cold: Assessing direct, indirect and physiological measures of lie detection.
Acta Psychol (Amst)
November 2024
Tilburg University, Netherlands.
People tend to be bad at detecting lies: When explicitly asked to infer whether others tell a lie or the truth, people often do not perform better than chance. However, increasing evidence suggests that implicit lie detection measures and potentially physiological measures may mirror observers' telling apart lies from truths after all. Implicit and physiological responses are argued to respond to lies as a threatening stimulus associated with a threat response.
View Article and Find Full Text PDFCommentary: Why is genetic testing underutilized worldwide? The case for hereditary breast cancer.
BJC Rep
October 2024
Women's College Research Institute, Women's College Hospital, Toronto, ON, Canada.
It is thirty years since the BRCA1 and BRCA2 genes were discovered and genetic testing for BRCA1 and BRCA2 was introduced. Despite increasing awareness of the genetic basis of cancer and our evolving knowledge of effective means of prevention, screening, and treatment for hereditary breast and ovarian cancers, genetic testing is underutilized, and most mutation carriers remain unidentified. In this commentary, we explore possible reasons for why this might be so.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!